glp-1 cardiovascular outcomes 2025 news Effects and Tolerability of Receptor Agonists: A Systematic Review and Meta-Analysis of 99,599 Patients Cardiovascular Risks after GLP-1 Discontinuation

8 Tips to Prepare for you GLP-1 Shot Day 1

Exenatide formulations show variable nausea rates: the twice-daily immediate-release preparation (Byetta) tends to produce higher rates of nausea (approximately 3050%), whilst the once-weekly extended-release formulation (Bydureon) demonstrates improved tolerability with nausea rates of approximately 1424%, according to their respective SmPCs

Step 3: Treatment Plan & Dosing Step 4: Ongoing Support Regular check-ins help us fine-tune your plan and manage progress safely

Yet little is known about what happens when therapy is discontinuedan increasingly important question as real-world discontinuation rates remain high

We used greedy nearest neighbour matching with a caliper of 0.1 pooled standard deviations

In studies where patients tapered off slowly, hunger hormones rose more gently, and weight regain was smaller